Abraham G Hartzema

Response to comment on 'empirical assessment of methods for risk identification in healthcare data'.

David Madigan, Patrick B Ryan, Paul E Stang, 2013, Statistics in medicine.

Utilizing Medicare claims data for real‐time drug safety evaluations: is it feasible? ,

Judith A Racoosin, Abraham G Hartzema, J. Racoosin, 2011, Pharmacoepidemiology and drug safety.

Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.

Abraham G Hartzema, A. Hartzema, Stacy A. Voils, 2017, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance

Andrew Bate, Yihua Xu, Brian C Sauer, 2015, Drug Safety.

Discordance Between Availability of Pharmacogenetics Studies and Pharmacogenetics-Based Prescribing Information for the Top 200 Drugs

Tobias Gerhard, Issam Zineh, Christina L Aquilante, 2006, The Annals of pharmacotherapy.

Planning for pharmacy health information technology in critical access hospitals.

Almut G Winterstein, Abraham G Hartzema, Robert Pannell, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.